CDW vs FDMT · P/E 22, rev $21.00B vs rev $37.0K
CDW Corp (CDW) versus 4D Molecular Therapeutics Inc (FDMT) — a side-by-side from cached financials, not a winner call.
CDW Corp (CDW) is a information technology services company listed on US.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Latest reported CDW revenue for 2024-12-31 was $21.00B. Net income was $1.08B. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CDW currently screens at market cap $23.36B and trailing P/E 22.0.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
CDW currently screens at market cap $23.36B and trailing P/E 22.0. FDMT currently screens at market cap $518.1M.
Not investment advice. Open the CDW and FDMT stock pages for the full models.
Not investment advice.